. LillyPad Aduro Biotech $ADRO to Develop STING Pathway Inhibitors for Autoimmune Diseases httpow.lyhGgk30n2TUlÂpic.twitter.comwrBq00Xxzo

. @LillyPad, Aduro Biotech ($ADRO) to Develop STING Pathway Inhibitors for Autoimmune Diseases: http://ow.ly/hGgk30n2TUl pic.twitter.com/wrBq00Xxzo

16:25 EST 22 Dec 2018 | Genetic Engineering News

. @LillyPad, Aduro Biotech ($ADRO) to Develop STING Pathway Inhibitors for Autoimmune Diseases: http://ow.ly/hGgk30n2TUl  pic.twitter.com/wrBq00Xxzo

More From BioPortfolio on ". @LillyPad, Aduro Biotech ($ADRO) to Develop STING Pathway Inhibitors for Autoimmune Diseases: http://ow.ly/hGgk30n2TUl pic.twitter.com/wrBq00Xxzo"